Hawryluk P. Kent

President & CEO at MBX

Sold, on record
$18k
Dollars the filings state
Form 4 sales
1
Latest May 6, 2026
Form 144 notices
3
Proposed sales
Quarters with a sale
1 of the last 8
1 day with a sale in that time
Companies
1
Filed as an executive or holder

Companies

  • MBXMBX Biosciences, Inc.President & CEO

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. Aug 17, 2026Notice

    MBX

    Filed a notice to sell 3,745 shares

    $256k3,745 shares

    Filed Aug 17, 2026Form 144

  2. Aug 4, 2026Notice

    MBX

    Filed a notice to sell 936 shares

    $62k936 shares

    Filed Aug 4, 2026Form 144

  3. May 6, 2026No plan

    MBX

    Sold 0.1% of their holdings

    $18k607 shares at $29.54

    Filed May 8, 2026Form 4

  4. May 6, 2026Notice

    MBX

    Filed a notice to sell 607 shares

    $18k607 shares

    Filed May 6, 2026Form 144

4 of 4

Every transaction

Every transaction on a Form 4 or Form 5 by Hawryluk P. Kent
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
May 6, 2026May 8, 2026MBXPresident & CEOSold607$29.54$18k727,667SEC
Mar 13, 2026Mar 16, 2026MBXPresident & CEOBought18,500$28.41$526k486,777SEC
Feb 26, 2026Feb 27, 2026MBXPresident & CEOExercised or settledStock option (right to buy)28,76891,668SEC
Feb 26, 2026Feb 27, 2026MBXPresident & CEOExercised options28,768$16.00$460k728,274SEC
Feb 2, 2026Feb 3, 2026MBXPresident & CEOAwardedStock option (right to buy)164,500164,500SEC
Feb 2, 2026Feb 3, 2026MBXPresident & CEOAwarded35,250699,506SEC
Oct 24, 2025Oct 28, 2025MBXPresident & CEOExercised or settledStock option (right to buy)182,859129,708SEC
Oct 24, 2025Oct 28, 2025MBXPresident & CEOExercised options182,859$3.25$594k664,256SEC
Oct 20, 2025Oct 21, 2025MBXPresident & CEOBought20,000$13.64$273k468,277SEC
Feb 4, 2025Feb 5, 2025MBXPresident & CEOBought50,000$10.69$535k448,277SEC
Feb 3, 2025Feb 5, 2025MBXPresident & CEOAwardedStock Option (Right to Buy)243,000243,000SEC
Sep 16, 2024Sep 17, 2024MBXPresident & CEOConvertedSeries A Convertible Preferred Stock4.8M0SEC
Sep 16, 2024Sep 17, 2024MBXPresident & CEOConverted399,760398,277SEC
Sep 12, 2024Sep 13, 2024MBXPresident & CEOAwardedStock Option (Right to Buy)120,436120,436SEC
Jan 29, 2018Jan 30, 2018MTVADirectorAwardedStock Option (right to buy)10,80010,800SEC
Mar 10, 2017Mar 14, 2017MTVADirectorBoughtWarrant to Purchase Common Stock18,750$9.47$178k18,750SEC
Mar 10, 2017Mar 14, 2017MTVADirectorBought25,000$9.47$237k81,889SEC
Aug 10, 2016Aug 12, 2016MTVADirectorBought25,000$10.00$250k56,889SEC
Aug 10, 2016Aug 12, 2016MTVADirectorOther816$6.71$5k8,273SEC
Aug 10, 2016Aug 12, 2016MTVADirectorConvertedSeries A Convertible Preferred Stock7,4570SEC
Aug 10, 2016Aug 12, 2016MTVADirectorConverted31,073$5.10$158k31,889SEC
Aug 4, 2016Aug 8, 2016MTVADirectorAwardedStock Option (right to buy)60,00060,000SEC

Sales and notices (4)

Form 144 notices and Form 4 sales by Hawryluk P. Kent
Source
Aug 17, 2026Aug 17, 2026MBXPresident & CEOForm 144 notice3,745$256kNoticeSEC
Aug 4, 2026Aug 4, 2026MBXPresident & CEOForm 144 notice936$62kNoticeSEC
May 6, 2026May 8, 2026MBXPresident & CEOForm 4 sale607$18k0.1%No planSEC
May 6, 2026May 6, 2026MBXPresident & CEOForm 144 notice607$18kNoticeSEC